PIONEERING EARLY CANCER DETECTION & TAILORED TREATMENT PLANS

Now in the 3rd year of trading and on the edge of an exciting revaluation.

Secure your EIS-approved investment guide now and discover how your contribution can reshape the landscape of cancer care.

Please complete the form to obtain further details

*Only available to sophisticated and HNW investors

£12,000 Minimum Investment

Frontier Diagnostics is HMRC-approved under the Enterprise Investment Scheme, giving qualifying investors access to significant tax advantages:

• 30% Income Tax Relief on the amount invested
• Capital Gains Tax exemption on exit - 0% on profits if held 3+ years
• Up to 45% Loss Relief - significantly limiting your downside
• Inheritance Tax exempt after 3 years under Business Property Relief

ENTERPRISE INVESTMENT SCHEME

THE PROBLEM

THE SOLUTION

Conventional cancer care is built on guesswork. Chemotherapy is prescribed from protocols that ignore individual biology — patients endure toxic treatments that may never have been right for them.

Biopsies are invasive, expensive, and capture only a single snapshot of a tumour at one point in time.

Post-treatment surveillance relies on MRI and CT scans that can miss early recurrence entirely. By the time it's detected, options are already running out.

Frontier's platform detects circulating tumour cells directly from a blood sample, giving clinicians a live window into what the cancer is doing right now.

During & after treatment — track response in real time, then monitor for recurrence with a simple blood test every 3–6 months. Earlier warning. Less cost.

During & after treatment — track response in real time, then monitor for recurrence with a simple blood test every 3–6 months. Earlier warning. Less cost.

Disclaimer: Any person accessing the email and considering potential investment opportunities featured in the email should make their own commercial assessment after seeking the advice of an appropriately authorised or regulated financial advisor. This email should not be construed as advice or a personal recommendation to any prospective investor. Investments of this nature carry risks to your capital and can go up or down. Past performance is not indicative of future results. This opportunity is only suitable for high net worth or self-sophisticated investors as defined; you will have an annual income in excess of £100K. Have net assets in excess of £250K beyond your pension fund assets and your private residence. You have been a Director of a company turning over at least £1 million within the last two years. You have made more than one investment in an unlisted company in the previous two years. You have been a member of a network or syndicate of business angels for at least six months. You have worked in the past two years in a professional capacity in the private equity sector or in the provision of finance for small and medium enterprises..